Thomas R. Kosten

1.4k total citations
16 papers, 910 citations indexed

About

Thomas R. Kosten is a scholar working on Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Thomas R. Kosten has authored 16 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Pharmacology. Recurrent topics in Thomas R. Kosten's work include Opioid Use Disorder Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Thomas R. Kosten is often cited by papers focused on Opioid Use Disorder Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Forensic Toxicology and Drug Analysis (5 papers). Thomas R. Kosten collaborates with scholars based in United States. Thomas R. Kosten's co-authors include Herbert D. Kleber, Charles A. Morgan, Bruce J. Rounsaville, Frank H. Gawin, Therese A. Kosten, Lawrence H. Price, S. Kelly Avants, Arthur Margolin, Jed Black and Elinore F. McCance‐Katz and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thomas R. Kosten

16 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas R. Kosten United States	15	482	253	220	202	194	16	910
Jonathan B. Kamien United States	24	772 1.6×	246 1.0×	238 1.1×	386 1.9×	234 1.2×	33	1.3k
J H Mendelson United States	24	808 1.7×	207 0.8×	274 1.2×	435 2.2×	360 1.9×	36	1.7k
S E Lukas United States	18	628 1.3×	136 0.5×	75 0.3×	276 1.4×	172 0.9×	31	1.0k
G. Moi Italy	17	342 0.7×	205 0.8×	142 0.6×	129 0.6×	127 0.7×	19	864
Arto J. Hiltunen Sweden	23	461 1.0×	188 0.7×	119 0.5×	120 0.6×	380 2.0×	66	1.3k
Thomas Kosten United States	17	325 0.7×	371 1.5×	367 1.7×	134 0.7×	189 1.0×	29	1.1k
Wilfrid N. Raby United States	19	363 0.8×	220 0.9×	152 0.7×	80 0.4×	252 1.3×	29	898
Peter Jatlow United States	18	482 1.0×	273 1.1×	112 0.5×	300 1.5×	246 1.3×	25	1.3k
C P O'Brien United States	11	520 1.1×	528 2.1×	207 0.9×	179 0.9×	116 0.6×	14	1.1k
Rudolf Stohler Switzerland	17	213 0.4×	365 1.4×	311 1.4×	79 0.4×	274 1.4×	57	1.1k

Countries citing papers authored by Thomas R. Kosten

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Kosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Kosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Kosten more than expected).

Fields of papers citing papers by Thomas R. Kosten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Kosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Kosten. The network helps show where Thomas R. Kosten may publish in the future.

Co-authorship network of co-authors of Thomas R. Kosten

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Kosten. A scholar is included among the top collaborators of Thomas R. Kosten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Kosten. Thomas R. Kosten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Oliveto, Alison, et al.. (2001). Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug and Alcohol Dependence. 63(2). 155–167. 27 indexed citations

Stine, Susan M., et al.. (2001). Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology. 154(3). 274–281. 32 indexed citations

Kosten, Thomas R., et al.. (1998). Regional cerebral blood flow during acute and chronic abstinence from combined cocaine–alcohol abuse. Drug and Alcohol Dependence. 50(3). 187–195. 34 indexed citations

Oliveto, Alison, Thomas R. Kosten, Richard S. Schottenfeld, Jean Falcioni, & Douglas Ziedonis. (1995). Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. Journal of Substance Abuse Treatment. 12(6). 423–428. 22 indexed citations

Margolin, Arthur, S. Kelly Avants, & Thomas R. Kosten. (1995). Mazindol for Relapse Prevention to Cocaine Abuse in Methadone-Maintained Patients. The American Journal of Drug and Alcohol Abuse. 21(4). 469–481. 42 indexed citations

Avants, S. Kelly, Arthur Margolin, Patrick Chang, Thomas R. Kosten, & Stephen Birch. (1995). Acupuncture for the treatment of cocaine addiction investigation of a needle puncture control. Journal of Substance Abuse Treatment. 12(3). 195–205. 47 indexed citations

Oliveto, Alison, et al.. (1995). Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 231–241. 31 indexed citations

Avants, S. Kelly, Arthur Margolin, & Thomas R. Kosten. (1994). Cocaine Abuse in Methadone Maintenance Programs: Integrating Pharmacotherapy with Psychosocial Interventions. Journal of Psychoactive Drugs. 26(2). 137–146. 20 indexed citations

Wallace, Elizabeth A., Thomas J. McMahon, H. Rowland Pearsall, et al.. (1994). Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug and Alcohol Dependence. 35(2). 141–149. 53 indexed citations

10.

Kosten, Thomas R.. (1994). Buprenorphine for benzodiazepine-abusing heroin addicts. American Journal of Psychiatry. 151(1). 151a–151. 8 indexed citations

11.

Kosten, Therese A., et al.. (1993). Gender differences in cocaine use and treatment response. Journal of Substance Abuse Treatment. 10(1). 63–66. 218 indexed citations

12.

McCance‐Katz, Elinore F., Lawrence H. Price, Christopher J. McDougle, et al.. (1993). Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology. 111(1). 39–46. 162 indexed citations

13.

Kosten, Thomas R., Charles R. Morgan, & Mary-Jeanne Kreek. (1992). Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: Preliminary findings. Biological Psychiatry. 32(6). 523–528. 26 indexed citations

14.

Kosten, Thomas R., et al.. (1992). Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.. PubMed. 121. 101–19. 23 indexed citations

15.

Kosten, Thomas R., et al.. (1990). Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence. 25(1). 73–78. 48 indexed citations

16.

Kosten, Thomas R., Herbert D. Kleber, & Charles A. Morgan. (1989). Treatment of cocaine abuse with buprenorphine. Biological Psychiatry. 26(6). 637–639. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact